A partnership of 5 leading research organizations have partnered to provide the most comprehensive clinical development platform in the industry. Leveraging their collective expertise, the Center for Diagnostic Imaging (CDI), Medtronic, MD Bioscience, Prism Research, and ThreeWire, have come together to make it easier for life science companies and clinicians to bring lifesaving and life improving products to patients in need. Dubbed the Minnesota Clinical Research Hub, this partnership provides sponsors with a flexible platform for conducting their trials, allowing use of the partners individually and collectively as research needs dictate. Eddie Moradian, CEO of MD Bioscience states, “We believe we can provide a better, more advanced service while positioning MN as the destination of choice for clinical studies”.
Clinical research is a major driver of the cost and time to bring a new therapy to market. According to PharmaFocus, November 2016, per patient costs in clinical trials went up 157% between 2008 and 2013. The MCRH partners are positioned to deliver maximum value for their sponsors via their flexible model and deep expertise in all facets of clinical trials. This flexibility ensures that research investments will be money well spent.
Clinician innovators will particularly benefit from the consortium’s breadth of services. Clinical research contributes to the expanding knowledge base of medicine and exposure to medical innovation. But barriers regarding participation have been formidable. Inadequate research experience and training, existing clinical practice duties, recruitment, lack of support staff and additional management and administrative duties have all impacted clinician interest and success. By removing these barriers, MCRH encourages and supports local clinician participation by providing a conduit to the organizational and operational infrastructures needed for successful clinical research study execution.
Why do all the work to get 5 separate businesses together? In the words of the consortium’s members they share the Medical Alley Association’s vision to “elevate Minnesota’s Medical Alley as the global epicenter of health innovation and care.” Jeff Cosgrove, President of Prism Research states, “The Twin Cities has always had the critical assets required to become a significant contributor to pharmaceutical advancements. This unprecedented partnership based on geographical proximity will provide all the necessary components to enhance Minnesota’s strong reputation as a leader in medical advancements.”
MCRH believes that through the strength and industry leadership of its members, in concert with local clinicians and life science companies, Minnesota will expand its recognition as an international destination for the clinical advancement of medical technologies. All the consortium members work nationally and globally to bring research to Minnesota’s Medical Alley. This partnership will expand their reach and value to sponsors.
If you are curious about the work, you can connect with the consortium at the Medical Alley Association's Annual Meeting on April 27th. MCRH has generously sponsored the 3rd Annual Meeting.